Jim Wu

Jim Wu has a diverse work experience in the field of bioanalytics and immunology. Jim is currently working as a Senior Scientist/Consultant at 4DMT, where they oversee anti-drug antibody and neutralizing antibody assay work for various clinical trials. Jim is also involved in setting up a new lab function for in-house bioanalytics.

Prior to this, Jim worked at Bayer Healthcare Pharmaceuticals for 13 years. In the beginning, from 2007 to 2010, they managed an assay group for protein biologics, monitoring activity and mass measurements. From 2010 to 2020, they managed a bioanalytics group as part of a global DMPK department. Their work in this role helped advance 26 biologics projects from research to development phase.

Before joining Bayer, Jim worked at Berlex Biosciences as a Research Scientist for nearly two decades, from 1988 to 2007. Jim also worked at Triton Biosciences as a Scientist, providing clinical trials assay support and conducting research on targeting small cell lung cancer. In the early stages of their career, they worked as a Staff Research Associate at UCSF, VAMC.

Overall, Jim Wu has extensive experience in the pharmaceutical industry, with a strong background in bioanalytics, immunology, and clinical trials.

Jim Wu has a Bachelor of Arts degree with a double major in Chemistry and Biology from the University of California, Santa Cruz. No specific start or end year for their education is mentioned.